Skip to main content

AdvaMed amended strategy and found success in tax fight

By digging in heels and changing its approach, association prevailed in eliminating policy that was top target for industry Whitaker When Scott Whitaker joined the Advanced Medical Technology Association as CEO in 2016, one policy aim took precedence above all others: ending the medical device tax. "It was the absolute top priority. There was no question about it," Whitaker told CEO Update. "It was part of every conversation I had with the board when I interviewed for the job and was at the top of the list of conversations I had from day one until the end of December this year." The medical device tax was a 2.3% excise tax placed on the sale of medical devices in the U.S.… Read More